You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oesophageal Squamous Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023

The Microbiome of Oesophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Cancer
  • Microbial Colonization
  • Upper endoscopy
  • Hong Kong, Hong Kong
    Prince of Wales Hospital
Aug 15, 2022

Oesophageal Squamous Cell Carcinoma Trial in Shanghai (PD-L1 Antibody SHR-1316)

Recruiting
  • Oesophageal Squamous Cell Carcinoma
  • PD-L1 Antibody SHR-1316
  • Shanghai, China
    180 Fenglin Road
Jun 12, 2022

Immunochemotherapy in Esophageal Cancer

Recruiting
  • Esophageal Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Nov 24, 2022

    Squamous Cell Carcinoma Trial in France (Onivyde, Paclitaxel)

    Recruiting
    • Squamous Cell Carcinoma
    • Amiens, France
    • +8 more
    Dec 6, 2021

    Squamous Cell Esophageal Carcinoma, Esophageal Cancer, Oesophageal Cancer Trial in Guangzhou (drug, radiation, procedure)

    Recruiting
    • Squamous Cell Esophageal Carcinoma
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 11, 2022

    Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

    Not yet recruiting
    • Advanced Cancer
    • +16 more
    • Fosifloxuridine Nafalbenamide
    • +3 more
    • Birmingham, United Kingdom
    • +3 more
    Feb 1, 2023

    Esophageal Squamous Cell Carcinoma Trial in Norway, Sweden (radiation, drug, procedure)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Neoadjuvant radiotherapy (arm A)
    • +5 more
    • Oslo, Norway
    • +8 more
    Mar 29, 2022

    Sequence and Time-of-day Infusion of immunoCHemotherapy Affect

    Completed
    • Esophagus Cancer
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Nov 24, 2022

      ICIs Plus Chemotherapy for Advanced ESCC.

      Active, not recruiting
      • Metastatic Esophageal Squamous Cell Carcinoma
      • Anti-PD-1 Immune Checkpoint Inhibitors
      • Bengbu, Anhui, China
      • +22 more
      Nov 21, 2021

      Oesophageal Adenocarcinoma, Squamous Cell Carcinoma, Solid Tumor Trial in United Kingdom (M6620, Cisplatin, Capecitabine)

      Completed
      • Oesophageal Adenocarcinoma
      • +2 more
      • Cardiff, United Kingdom
      • +4 more
      Apr 27, 2022

      Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part

      Completed
      • Esophageal Squamous Cell Carcinoma
      • Nivolumab
      • Truro, Cornwall, United Kingdom
      • +35 more
      May 18, 2022

      Head and Neck Squamous Cell Carcinoma, Lung Cancer, Oesophageal Cancer Trial in Villejuif (Durvalumab, Tremelimumab, SBRT)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +2 more
      • Villejuif, Val De Marne, France
        Gustave Roussy
      Jul 21, 2021

      Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

      Active, not recruiting
      • Oesophageal Squamous Cell Carcinoma
      • +4 more
      • Duarte, California
      • +39 more
      Oct 31, 2022

      Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • +2 more
      • LDRT+CFRT
      • +2 more
      • Shanghai, China
      • +1 more
      Aug 3, 2023

      Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Head and Neck Squamous Cell Carcinoma
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Oct 25, 2023

      Bladder Cancer, Triple Negative Breast Cancer, Castration-resistant Prostate Cancer Trial in London, Oxford (HMBD-001)

      Recruiting
      • Bladder Cancer
      • +13 more
      • London, United Kingdom
      • +1 more
      Dec 13, 2021

      PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

      Not yet recruiting
      • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
      • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
      • (no location specified)
      Sep 24, 2023

      Esophageal Squamous Cell Carcinoma in Malawi

      Completed
      • Esophageal Squamous Cell Carcinoma
        • Lilongwe, Malawi
        • +1 more
        Jan 5, 2023

        Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)

        Not yet recruiting
        • Esophagus Cancer
        • Guangzhou, Guangdong, China
          Sun Yat-sen University
        Nov 20, 2023

        Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Moderately hypofractionated conformal radiation combined With S-1)

        Completed
        • Esophageal Squamous Cell Carcinoma
        • Moderately hypofractionated conformal radiation combined With S-1
        • Guangzhou, Guangdong, China
          Hui Liu
        Oct 25, 2022

        Carcinoma, Squamous Cell, Oesophageal Cancer Trial in Amsterdam (External beam radiotherapy, Bintrafusp alfa, Paclitaxel)

        Recruiting
        • Carcinoma, Squamous Cell
        • Oesophageal Cancer
        • External beam radiotherapy
        • +3 more
        • Amsterdam, Netherlands
          Academic Medical Center, Medical Oncology
        Jan 15, 2021

        Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

        Not yet recruiting
        • Squamous Cell Carcinoma
          • San Francisco, California
            Power Life Sciences
          Jun 23, 2023

          Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma

          Recruiting
          • Esophageal Cancer
          • Adjuvant Radiotherapy
          • Beijing, Chaoyang, China
            Cancer Institute and Hospital, Chinese Academy of Medical Scienc
          Jul 13, 2022

          Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

          Recruiting
          • Metastatic Esophageal Squamous Cell Carcinoma
          • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
          • Qingdao, Shandong, China
          • +1 more
          Nov 13, 2023